Form 4 for EW Edwards Lifesciences
Accepted 2025-02-18 00:00:00 ET · period of report 2025-02-16 · accession 0001225208-25-001909 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-02-18 | 2025-02-16+ | EW | Lippis Daniel J. | CVP, JAPAC | F - Tax | $76.19 | -601 | 22.6K | -3% | -$45.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-17 | F | D | 165 | $76.19 | 22,810.07 | D | — | — | |
| 2 | Common | Common Stock | 2025-02-16 | F | D | 214 | $76.19 | 22,975.07 | D | — | — | |
| 3 | Common | Common Stock | 2025-02-18 | F | D | 222 | $76.19 | 22,588.07 | D | — | — |